Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Ninna Kjaer Nielsen"'
Autor:
Simone Buchardt Brandt, Stefanie Korsgaard Körner, Rikke Vilsbøll Milling, Ninna Kjær Nielsen, Pernille Skjold Kingo, Ulla Nordström Joensen, Lasse Bro, Thor Knak Jensen, Astrid Helene Livbjerg, Knud Fabrin, Marie-Louise Vrang, Michael Vangedal, Gitte Wrist Lam, Jørgen Bjerggaard Jensen
Publikováno v:
European Urology Open Science, Vol 60, Iss , Pp 8-14 (2024)
Background: Approximately 15% of patients undergoing radical cystectomy (RC) develop benign ureteroenteric strictures. Of these strictures, the majority are located in the left ureter. To lower the rate of strictures, a retrosigmoid ileal conduit has
Externí odkaz:
https://doaj.org/article/6b03670dd27046cb88514c852a53ef89
Potential candidates for en bloc resection among patients with primary and recurrent bladder tumours
Autor:
Pernille Skjold Kingo, Jørgen Bjerggaard Jensen, Jakob Kristian Jakobsen, Ninna Kjaer Nielsen
Publikováno v:
Kjaer Nielsen, N, Jakobsen, J K, Kingo, P S & Jensen, J B 2021, ' Potential candidates for en bloc resection among patients with primary and recurrent bladder tumours ', Scandinavian Journal of Urology, vol. 55, no. 5, pp. 366-371 . https://doi.org/10.1080/21681805.2021.1954686
INTRODUCTION: Transurethral resection (TURB) is the gold standard treatment for non-muscle invasive bladder cancer (NMIBC). However, conventional TURB is possibly part of the mechanism leading to the high recurrence rate in NMIBC and the need for rep
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::217b5b69d0ecf1a168cfcf8527f424e8
https://pubmed.ncbi.nlm.nih.gov/34279178
https://pubmed.ncbi.nlm.nih.gov/34279178
Autor:
Knud Fabrin, Ninna Kjaer Nielsen, Gitte Wrist Lam, Peter Thind, Jørgen Bjerggaard Jensen, Per Holt
Publikováno v:
Nielsen, N, Wrist Lam, G, Fabrin, K, Holt, P, Thind, P O & Jensen, J B 2019, ' Reasons why not all Danish patients with muscle invasive bladder cancer receive neoadjuvant chemotherapy before radical cystectomy ', Scandinavian Journal of Urology, vol. 53, no. 4, pp. 213-216 . https://doi.org/10.1080/21681805.2019.1624608
Background: Danish guidelines on muscle invasive bladder cancer (MIBC) recommend neoadjuvant chemotherapy (NAC) for non-metastatic patients fit for cisplatin-based chemotherapy. The current indication is urothelial MIBC in patients less than 75 years
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0560b61971bbf991b80bd6f780c98118
https://pubmed.ncbi.nlm.nih.gov/31174449
https://pubmed.ncbi.nlm.nih.gov/31174449